Literature DB >> 31257422

Waning of Influenza Vaccine Protection: Exploring the Trade-offs of Changes in Vaccination Timing Among Older Adults.

Jill M Ferdinands1, Elif Alyanak1,2, Carrie Reed1, Alicia M Fry1.   

Abstract

BACKGROUND: In recent studies of influenza vaccine effectiveness (VE), lower effectiveness with increasing time since vaccination was observed, raising the question of optimal vaccination timing. We sought to evaluate the estimated number of influenza-associated hospitalizations among older adults due to potential changes in vaccination timing.
METHODS: Using empirical data and a health state transition model, we estimated change in influenza-associated hospitalizations predicted to occur among the US population aged ≥65 years if vaccination were delayed until October 1. We assumed the vaccination timing, coverage, and effectiveness observed in 2012-2013 as a prototypical influenza season, approximately 7% monthly waning of VE, and that between 0% and 50% of individuals who usually get vaccinated earlier than October failed to get vaccinated. We also assessed change in influenza-associated hospitalizations if vaccination uptake shifted substantially toward August and September.
RESULTS: In a typical season, delaying vaccination until October increased influenza hospitalizations if more than 14% of older adults usually vaccinated in August and September failed to get vaccinated. The consequences of delayed vaccination depended heavily on influenza season timing, rate of waning, and overall VE. A shift toward vaccination in August and September led to, on average, an increase in influenza-associated hospitalizations, but this result was also sensitive to influenza season timing.
CONCLUSIONS: Consequences of delayed vaccination varied widely. Uncertainties about vaccine waning and effects of a delay on vaccine coverage suggest it is premature to change current vaccine recommendations, although it may be prudent to prevent a substantial shift toward early vaccination. Published by Oxford University Press for the Infectious Diseases Society of America 2019.

Keywords:  adults; influenza; vaccine; vaccine effectiveness; waning vaccine effectiveness

Mesh:

Substances:

Year:  2020        PMID: 31257422     DOI: 10.1093/cid/ciz452

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

1.  Anomalous influenza seasonality in the United States and the emergence of novel influenza B viruses.

Authors:  Rebecca K Borchering; Christian E Gunning; Deven V Gokhale; K Bodie Weedop; Arash Saeidpour; Tobias S Brett; Pejman Rohani
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-02       Impact factor: 11.205

2.  Waning Vaccine Protection against Influenza among Department of Defense Adult Beneficiaries in the United States, 2016-2017 through 2019-2020 Influenza Seasons.

Authors:  Wenping Hu; Paul A Sjoberg; Anthony C Fries; Laurie S DeMarcus; Anthony S Robbins
Journal:  Vaccines (Basel)       Date:  2022-06-01

3.  Waning of Measured Influenza Vaccine Effectiveness Over Time: The Potential Contribution of Leaky Vaccine Effect.

Authors:  Jerome I Tokars; Manish M Patel; Ivo M Foppa; Carrie Reed; Alicia M Fry; Jill M Ferdinands
Journal:  Clin Infect Dis       Date:  2020-12-17       Impact factor: 9.079

4.  Waning Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2015-2016 to 2018-2019, United States Hospitalized Adult Influenza Vaccine Effectiveness Network.

Authors:  Jill M Ferdinands; Manjusha Gaglani; Emily T Martin; Arnold S Monto; Donald Middleton; Fernanda Silveira; H Keipp Talbot; Richard Zimmerman; Manish Patel
Journal:  Clin Infect Dis       Date:  2021-08-16       Impact factor: 9.079

5.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season.

Authors:  Lisa A Grohskopf; Elif Alyanak; Karen R Broder; Emmanuel B Walter; Alicia M Fry; Daniel B Jernigan
Journal:  MMWR Recomm Rep       Date:  2019-08-23

6.  Influenza in temperate and tropical Asia: a review of epidemiology and vaccinology.

Authors:  Barnaby Edward Young; M Chen
Journal:  Hum Vaccin Immunother       Date:  2020-02-04       Impact factor: 3.452

7.  Impact of Low Rates of Influenza on Next-Season Influenza Infections.

Authors:  Mary G Krauland; David D Galloway; Jonathan M Raviotta; Richard K Zimmerman; Mark S Roberts
Journal:  Am J Prev Med       Date:  2022-02-24       Impact factor: 5.043

8.  Ascertainment of vaccination status by self-report versus source documentation: Impact on measuring COVID-19 vaccine effectiveness.

Authors:  Meagan Stephenson; Samantha M Olson; Wesley H Self; Adit A Ginde; Nicholas M Mohr; Manjusha Gaglani; Nathan I Shapiro; Kevin W Gibbs; David N Hager; Matthew E Prekker; Michelle N Gong; Jay S Steingrub; Ithan D Peltan; Emily T Martin; Raju Reddy; Laurence W Busse; Abhijit Duggal; Jennifer G Wilson; Nida Qadir; Christopher Mallow; Jennie H Kwon; Matthew C Exline; James D Chappell; Adam S Lauring; Adrienne Baughman; Christopher J Lindsell; Kimberly W Hart; Nathaniel M Lewis; Manish M Patel; Mark W Tenforde
Journal:  Influenza Other Respir Viruses       Date:  2022-07-11       Impact factor: 5.606

9.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.

Authors:  Lisa A Grohskopf; Lenee H Blanton; Jill M Ferdinands; Jessie R Chung; Karen R Broder; H Keipp Talbot; Rebecca L Morgan; Alicia M Fry
Journal:  MMWR Recomm Rep       Date:  2022-08-26

10.  Seasonal influenza vaccination in Kenya: an economic evaluation using dynamic transmission modelling.

Authors:  Jeanette Dawa; Gideon O Emukule; Edwine Barasa; Marc Alain Widdowson; Omu Anzala; Edwin van Leeuwen; Marc Baguelin; Sandra S Chaves; Rosalind M Eggo
Journal:  BMC Med       Date:  2020-08-20       Impact factor: 8.775

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.